Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-15-077873
Filing Date
2015-11-12
Accepted
2015-11-12 06:04:48
Documents
1
Period of Report
2015-11-10

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 2884
  Complete submission text file 0001104659-15-077873.txt   4609
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Reporting) CIK: 0001121404 (see all company filings)

State of Incorp.: I0 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37625 | Film No.: 151221048
SIC: 2834 Pharmaceutical Preparations

Mailing Address 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Issuer) CIK: 0001640266 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)